FDA Approves Ninlaro (Ixazomib) for Multiple Myeloma
FDA Approves Darzalex (Daratumumab) for Multiple Myeloma
The US Food and Drug Administration (FDA) has approved the first monoclonal antibody to treat people with multiple myeloma, a type of cancer that starts in plasma cells.
Sitting Too Much Increases Cancer Risk in Women
Researchers from the American Cancer Society have found that women who spend 6 hours or more of free time sitting per day have a 10% greater risk of getting cancer than women who spend less than 3 hours of free time sitting per day.
FDA Approves Farydak (Panobinostat) for Multiple Myeloma
The US Food and Drug Administration (FDA) has approved Farydak (panobinostat) for people with multiple myeloma.
FDA Approves Generic Version of Doxil to Address Shortage
The US Food and Drug Administration (FDA) has approved the first generic version of the cancer drug Doxil (doxorubicin liposome).
Report Studies Link between World Trade Center Exposure and Cancer Risk
A study of people exposed to Ground Zero has found that early responders and recovery workers at site of the World Trade Center terrorist attack do not appear to have an increased risk of cancer overall thus far.